GLP-1 medications are especially effective for individuals managing diabetes, as they lower blood sugar and contribute to improved metabolic health
Choosing Between Compounded GLP-1 Formulations for Your Profile PlexusDx offers four primary compounded pathways: oral semaglutide, compounded semaglutide injection, oral tirzepatide, and compounded tirzepatide injection
doi: 10.1097/MPG.0b013e3181c992d6
Diabetologia 59 , 17431752 (2016)
Limitations of Use: Wegovy should not be used in combination with other semaglutide-containing products or any other GLP-1 receptor agonist The safety and efficacy of coadministration with other products for weight loss have not been established Wegovy has not been studied in patients with a history of pancreatitis Who should not use Wegovy
Their findings showed: Osteoporosis: About 4% of GLP-1 users developed osteoporosis, compared with just over 3% of non-users Osteomalacia (softening of the bones): Occurred nearly twice as often among GLP-1 users Gout: Occurred in 7.4% of GLP-1 users vs
